夹层后动脉瘤复杂腔内治疗的结果
基于血管质量倡议(VQI)2014至2021年数据,比较夹层后与退行性肾旁及胸腹动脉瘤的腔内修复围术期和长期结果。夹层后动脉瘤123例、退行性3635例,夹层后修复更多采用分期方式且多为广泛胸腹主动脉瘤,围术期调整后结果相似,但夹层后修复技术成功率较低且3年再干预显著更高。
要点
- 夹层后动脉瘤修复中36%采用分期方式,退行性修复为6.7%(p < .001)。
- 夹层后动脉瘤84%为广泛胸腹主动脉瘤,退行性为22%(p < .001)。
- 夹层后修复技术成功率75% vs 退行性83%(p = .018),3年再干预显著更高(p < .001)。
核心结论
- 慢性夹层后动脉瘤的复杂腔内修复可行,但与高再干预率及不可忽视的技术失败率相关。
- 需要更多数据评估这些手术的长期耐久性以及集中化开展这些复杂手术的效用。
研究设计与样本
- 研究血管质量倡议(VQI)2014至2021年所有完整肾旁和胸腹主动脉瘤的腔内修复,比较退行性与夹层后动脉瘤的围术期和长期结果。
- 围术期结果采用混合效应逻辑回归比较,长期结果采用Medicare linkage分析。
- 夹层后动脉瘤123例,退行性动脉瘤3635例。
主要发现
- 夹层后修复36%采用分期方式,退行性修复6.7%采用分期方式(p < .001)。
- 夹层后动脉瘤84%为广泛胸腹主动脉瘤(Crawford 1、2、3、5型),退行性动脉瘤为22%(p < .001)。
- 夹层后修复的主要类型为医师改良覆膜支架(73%),退行性修复主要为市售开窗支架(48%)。
- 分期手术第一阶段的围术期死亡率为2.8%,脊髓缺血为5.1%,胸腹改变生活事件(围术期死亡、卒中、永久性脊髓缺血和透析的复合终点)为8.9%。
- 最终阶段手术和透视时间相似,但夹层后修复技术成功率较低(75% vs 83%,p = .018),原因包括主体覆膜支架或桥接血管问题(11% vs 6.6%,p = .055)及完成时1型和3型内漏(17% vs 10%,p = .035)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Reports of endovascular treatment of chronic post-dissection aneurysms are limited to high volumes centres, posing questions about generalisability. METHODS: All endovascular repairs of intact pararenal and thoraco-abdominal aneurysms in the Vascular Quality Initiative from 2014 to 2021 were studied, and peri-operative and long term outcomes were compared between repairs of degenerative and post-dissection aneurysms. Peri-operative outcomes were compared using mixed effects logistic regression, and long term outcomes using Medicare linkage. RESULTS: There were 123 patients who completed treatment for post-dissection aneurysms and 3 635 for degenerative aneurysms, with 36% of post-dissection repairs and 6.7% of degenerative repairs performed in a staged fashion (p < .001). The majority (84%) of post-dissection aneurysms were extensive thoraco-abdominal aneurysms (TAAAs: Crawford Type 1, 2, 3, 5), compared with 22% of degenerative aneurysms (p < .001). Physician modified endografts were the primary repair type for post-dissection (73%), while commercially available fenestrated grafts were the dominant repair for degenerative (48%). The first stage of staged procedures was associated with a 2.8% peri-operative mortality rate, 5.1% spinal cord ischaemia, and 8.9% thoraco-abdominal life altering events (the composite of peri-operative death, stroke, permanent spinal cord ischaemia, and dialysis). Th final stage procedure and fluoroscopy times were similar, but technical success was lower in post-dissection repairs (75% vs. 83%, p = .018), both due to issues with the main endograft or bridging vessels (11% vs. 6.6%, p = .055), and types 1and 3 endoleak at completion (17% vs. 10%, p = .035). In addition, high volume surgeons had two fold higher odds of technical success than their low volume counterparts. Adjusted peri-operative outcomes were similar between pathology types, including when comparisons were restricted to extensive TAAAs. Crude and adjusted three year survival were similar, but three year re-interventions were significantly higher following post-dissection repairs (p < .001). CONCLUSION: Complex endovascular repair of chronic post-dissection aneurysms is feasible but is associated with high rates of re-interventions and non-trivial rates of lack of technical success. More data are needed to evaluate the long term durability of these procedures, and the utility of centralising these complex procedures.
引用
- O'Donnell TFX, Patel PB, Marcaccio CL, et al. Outcomes of Complex Endovascular Treatment of Post-Dissection Aneurysms. Eur J Vasc Endovasc Surg. 2023. PMID: 37087065. doi:10.1016/j.ejvs.2023.04.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。